Wij gebruiken cookies voor het bieden van een gebruikersvriendelijke ervaring. Als u doorgaat met het gebruik van de website, geeft u toestemming voor het gebruik van cookies. Lees ons privacybeleid voor meer informatie of het instellen van uw eigen voorkeuren.
Discover whether investor engagement on climate change is having a real-world impact.
Macro Update 19 April 2021
Lees alles over onze stewardship highlights in 2020 en download het verslag voor meer informatie.
Keep up to date with responsible investing through our monthly roundup of highlights – interesting events, articles we’re reading, podcasts we’re enjoying and more.
The prospect of a vaccine trade war promoted by the EU is a worry in the context of markets that have come a long way in the last 12 months.
Huge, technological forces are reshaping the world. How can investors remain on the right side?
Discover the road we’re taking to achieve net zero emissions across all assets under management.
The 2021 Access to Medicine Index reveals how big pharma is tackling health and healthcare access inequalities.
Today, we launched the BMO Climate Institute, committed to a Net Zero 2050 target, and declared our ambition to be our clients’ lead partner in the transition to a net zero world
The way we travel is unsustainable. Which companies are leading the search for solutions?
Keep up to date with responsible investing through our monthly roundup of highlights – interesting events, articles we’re reading, podcasts we’re enjoying and more.
Discover how artificial intelligence and automation could impact the future of work.
Discover how the Covid-19 pandemic has already deepened existing gender inequalities – and why women must be at the heart of the recovery.
Discover what positive and negative ESG issues apply to Bitcoin and whether the cryptocurrency is a responsible investment.
Historically difficult for investors to define and quantify, social issues are now among the most pressing issues for companies globally – discover our engagement on some of these issues, including antimicrobial resistance in Q4 2020.
After a year that prompted many investors to offload risk, BMO Global Asset Management assert the case for staying the course in this strategic asset class
Macro Update 22 February 2021
